Allegion’s shares rose 11.0% after earnings, as 7.2% organic revenue growth, margin expansion and a higher full-year outlook showed stronger demand—particularly in the Americas. The outlook still points to difficult conditions in Western Europe and a limited medium-term recovery in Residential.
- Q3 revenue was approximately $1.2 billion, up 9.6% year over year; organic revenue grew 7.2%, driven by price and volume.
- Adjusted operating margin increased 60 basis points to 24.7%. Price and productivity net of inflation and investment added $15.6 million and 50 basis points to the margin rate; acquisitions were a 20-basis-point headwind.
- Adjusted EPS rose 13% to $2.60. Year-to-date available cash flow was $539.4 million, up 11.2%.
- Full-year outlook was raised to 9.5%–10.5% reported revenue growth, 5%–6% organic revenue growth and adjusted EPS of $9.05–$9.10.
- Americas Non-Residential delivered low-double-digit organic growth, with strength expected to continue into 2027. Management said Western Europe remains difficult, while inflation and interest rates make a strong medium-term Residential recovery hard to forecast.
Community Discussion